Adam Slivka, MD
Gastroenterology · Pittsburgh, PANPI 1447225578
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 10 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Boston Scientific accounts for 91.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for gastroenterology clinicians in PA, where the typical reported total is $1,806.
Across 10 payments — averaging $90.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$826
- Ambu Inc.$75
Across 75 payments — averaging $12,012 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$517K
- Olympus Corporation$236K
- Olympus Corporation Of The Americas$148K
What the payments were for
- Food & beverage$901100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $826 |
| Ambu Inc. | 1 | $75 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BILIARY STENT INTRODUCER$146
- SPYGLASS$132
- EXALT Model D$127
How this compares
$901 in reported general payments places this provider in the 35th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 157 | $513,815 |
| ZenpepLipase/Protease/Amylase | 38 | $118,486 |
| MotegrityPrucalopride Succinate | 22 | $13,648 |
| Ursodiol | 44 | $5,449 |
| Omeprazole | 207 | $2,506 |
| Dexlansoprazole DrDexlansoprazole | 12 | $2,165 |
| Nortriptyline Hcl | 62 | $959 |
| Ondansetron OdtOndansetron | 28 | $860 |
| Pantoprazole Sodium | 57 | $743 |
| Lansoprazole | 13 | $221 |
| Famotidine | 11 | $149 |
| Rabeprazole Sodium | 13 | $134 |
| Prochlorperazine Maleate | 13 | $131 |
| Ciprofloxacin Hcl | 27 | $89 |
| Metoclopramide Hcl | 19 | $82 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Pittsburgh
- Miguel RegueiroPittsburgh$1.5M
- Sandra El-HachemPittsburgh$472K
- Elie AounPittsburgh$323K
- Gursimran KochharPittsburgh$217K
- Michael BabichPittsburgh$157K
- Heitham Abdul-BakiPittsburgh$92K
- Katie FarahPittsburgh$55K
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Harshit KharaDanville$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.